Hydroxychloroquine for COVID-19: Balancing contrasting claims. (2020)
Attributed to:
COVID-19: multi-arm, multi stage adaptive clinical trial (CoV-MAMS)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejim.2020.11.018
PubMed Identifier: 33243609
Publication URI: http://europepmc.org/abstract/MED/33243609
Type: Journal Article/Review
Volume: 82
Parent Publication: European journal of internal medicine
ISSN: 0953-6205